Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 89,207 | 89,804 | 86,521 | 80,316 | 79,482 |
| Cost of Goods | 52,690 | 54,041 | 51,803 | 49,452 | 49,356 |
| Gross Profit | 36,517 | 35,763 | 34,718 | 30,864 | 30,126 |
| Operating Expenses | 38,182 | 38,103 | 37,156 | 36,432 | 36,061 |
| Operating Income | -975 | -2,299 | -1,635 | -5,116 | -5,579 |
| Interest Expense | 241 | 320 | 312 | 242 | 241 |
| Other Income | -232 | 25 | 235 | 37 | 264 |
| Pre-tax Income | -1,448 | -2,594 | -1,712 | -5,321 | -5,556 |
| Income Tax | 335 | 207 | 290 | 273 | 307 |
| Net Income Continuous | -1,783 | -2,801 | -2,002 | -5,594 | -5,863 |
| Minority Interests | -507 | -131 | -315 | -267 | -205 |
| Net Income | $-1,276 | $-2,670 | $-1,687 | $-5,327 | $-5,658 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.03 | -0.08 | -0.09 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.03 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.03 | -0.08 | -0.09 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.03 | -0.09 | -0.09 |
| EBITDA(a) | $6,761 | $5,176 | $6,132 | $2,677 | $2,101 |